BioBio ApS: Financial statements 2023
CVR: 42187542
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioBio ApS (CVR 42187542) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 9,049 and a net result of DKK 5,346 compared with DKK 87,404 the year before. That is a decrease of 92% compared with the year before. Equity in the 2023 report amounted to DKK 207,681. The solvency ratio was 78.6%.
- Gross Profit
- DKK 9,049
- Profit/Loss
- DKK 5,346
- Equity
- DKK 207,681
- Total Assets
- DKK 264,283
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 9K | 5K | 208K | - |
| 2022 | - | 113K | 87K | 202K | - |
| 2021 | - | 107K | 75K | 115K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioBio ApS has published its annual report for 2022. Gross profit came to DKK 112,640, and the net result was DKK 87,404.
About BioBio ApS
BioBio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2021. The company is registered under the industry Industrielt design og modedesign. The management consists of Katrine Helt Schaarup. The company is owned by Twenty/Twenty ApS. In 2025, the company reported a gross profit of DKK -25,354 and a net result of DKK -20,224 compared with DKK -21,169 the year before. Equity in the 2025 report amounted to DKK 166,288.